Home
Resources
Product Analysis
Acknowledgements
About
Home
References
Market status
Market status
Early Stage Concept
Products 31 to 40 of 69
Modify Display Properties
Biotech components
Business models
Country of production
Country of distribution
Intended consumer
Date added
Date last modified
Known funding amount
Funding types
Industry
Market status
Organization
Organization type(s)
Product categories
Production process
Source
Trading symbol
Value chain stage
Sort: Title (A-Z)
Date added (oldest-newest)
Date added (newest-oldest)
Date modified (oldest-newest)
Date modified (newest-oldest)
Title (A-Z)
Title (Z-A)
Organization (A-Z)
Organization (Z-A)
Florian™ “On Demand” Flowering
by
Intrexon
Biotech components:
Gene Editing
+
Plant
Business models:
B2C
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2019/09/12 14:47 (5 years ago)
Date last modified:
2019/09/12 14:47 (5 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Food & Agriculture
+
Novelty
Market status:
Early Stage Concept
Organization type(s):
Public Company
Product categories:
Plant
Production process:
N/A
Source:
N/A
Trading symbol:
XON
(NASDAQ)
Value chain stage:
Finished Product
Gen 3 technical and medical fiber
by
Kraig Biocraft Laboratories
Biotech components:
Animal
Business models:
B2B
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/08/30 11:49 (6 years ago)
Known funding amount:
1,200,000 USD
Funding types:
Shareholder Investment
+
Government
Industry:
Medical
+
Industrial
Market status:
Early Stage Concept
Organization type(s):
Public Company
Product categories:
Fiber
Production process:
Closed Production
Source:
Web search
Trading symbol:
KBLB
(OTCQB)
Value chain stage:
Input
Genetic Security System
by
Wyss Institute
+
Harvard University
Biotech components:
Bacteria
Business models:
B2B
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/08/30 11:49 (6 years ago)
Known funding amount:
3,700,000 USD
Funding types:
Government
Industry:
Security
Market status:
Early Stage Concept
Organization type(s):
Research Institution
Product categories:
Forensic Tagging
Production process:
Closed Production
Source:
NASEM Database
Trading symbol:
N/A
Value chain stage:
Input
Gluten Reduced Wheat
by
Catalyxt
Biotech components:
Plant
Business models:
B2C
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/08/30 11:49 (6 years ago)
Known funding amount:
608,825,000 USD
Funding types:
Shareholder Investment
Industry:
Food & Agriculture
Market status:
Early Stage Concept
Organization type(s):
Public Company
Product categories:
Plant
Production process:
Open Release
Source:
Web search
Trading symbol:
CLXT
(NASDAQ)
Value chain stage:
Finished Product
GM Yeast to make Cannabis
by
University of California, Berkeley
+
Demetrix Inc.
Biotech components:
Yeast
Business models:
B2B
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2019/09/12 15:18 (5 years ago)
Date last modified:
2019/09/12 15:18 (5 years ago)
Known funding amount:
11,000,000 USD
Funding types:
Venture Capital
Industry:
Medical
Market status:
Early Stage Concept
Organization type(s):
Private Company
+
University
Product categories:
Medicine
Production process:
N/A
Source:
Scientist Magazine
Trading symbol:
N/A
Value chain stage:
Input
GMO Low-Fat Pigs
by
Institute of Zoology at the Chinese Academy of Sciences
Biotech components:
Animal
Business models:
B2B
Country of production:
China
Country of distribution:
China
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/10/08 14:49 (6 years ago)
Known funding amount:
N/A
Funding types:
Government
Industry:
Food & Agriculture
Market status:
Early Stage Concept
Organization type(s):
Research Institution
+
University
Product categories:
Animal
Production process:
Open Release
Source:
Web search
Trading symbol:
N/A
Value chain stage:
Finished Product
Improved Rubisco
by
ARC Center of Excellence for Translational Photosynthesis at the Australian National University
Biotech components:
Bacteria
Business models:
B2B
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2020/12/18 14:38 (4 years ago)
Date last modified:
2020/12/18 14:38 (4 years ago)
Known funding amount:
N/A
Funding types:
University
Industry:
Food & Agriculture
Market status:
Early Stage Concept
Organization type(s):
University
Product categories:
Plant
Production process:
N/A
Source:
Web search
Trading symbol:
N/A
Value chain stage:
Input
Insulin-producing bacteria
by
Venter Institute
Biotech components:
Bacteria
Business models:
B2C
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/10/01 09:50 (6 years ago)
Known funding amount:
50,000 USD
Funding types:
Foundation
Industry:
Health
Market status:
Early Stage Concept
Organization type(s):
Research Institution
Product categories:
Medical Treatment
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
N/A
Value chain stage:
Finished Product
Mandelic Acid
by
MONAD Nanotech
+
Birla College
Biotech components:
Plant
Business models:
B2B
Country of production:
India
Country of distribution:
N/A
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/08/30 11:49 (6 years ago)
Known funding amount:
N/A
Funding types:
University
+
Government
Industry:
Health
Market status:
Early Stage Concept
Organization type(s):
University
Product categories:
Personal Care (Topical)
+
Medical Treatment
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
N/A
Value chain stage:
Input
Mast-MO (antibiotic wasp venom)
by
University of Pennsylvania’s Perelman School of Medicine
Biotech components:
Animal
+
Bacteria
+
Molecule
Business models:
B2B
+
B2C
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2020/12/18 14:40 (4 years ago)
Date last modified:
2020/12/18 14:40 (4 years ago)
Known funding amount:
N/A
Funding types:
University
Industry:
Medical
Market status:
Early Stage Concept
Organization type(s):
University
Product categories:
Medical Treatment
Production process:
N/A
Source:
Web search
Trading symbol:
N/A
Value chain stage:
Input
1
2
3
4
5
6
7
Login
or
register
to add and edit products
Future
Bioengineered
Products
Home
Resources
Product Analysis
Acknowledgements
About
